Infinity Pharmaceuticals (NASDAQ:INFI) Will Have To Spend Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business lost money for years while it grew recurring revenue, if you held shares since 2005, you’d have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed.
So should Infinity Pharmaceuticals (NASDAQ:INFI) shareholders be worried about its cash burn? For …

Click here to view the original article.